Zim Laboratories
add_icon

Zim Laboratories

119.43
+5.46
(4.79%)
Market Cap
639.54 Cr
PE Ratio
104.59
Volume
3,09,307.00
Day High - Low
119.66 - 109.00
52W High-Low
127.00 - 59.31
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
639.54 Cr
EPS
1.19
PE Ratio
104.59
PB Ratio
2.08
Book Value
54.86
EBITDA
41.40
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
1.97
Debt to Equity
0.45
Forecast For
Actual

Company News

View All News
Caret
neutral
Dr. Anwar Daud acquired 80,000 shares from Mr. Zulfiqar Kamal at ₹107.50 per share. The transfer increases Daud's holding to 25.05%.
neutral
Zim Laboratories Ltd will hold a virtual one-on-one investor meet on June 17, 2026, with Long Equity. No unpublished price sensitive information will be shared.
neutral
Dr. Anwar Daud will acquire 80,000 equity shares from Mr. Zulfiquar Kamal on or after June 11, 2026. The transfer represents 0.15% of the paid-up equity share capital.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,838.30
#1 4,41,069.75
38.02
#1 58,220.10
6.38
#1 11,565
25.80
59.20
6,743.00
1,79,005.46
69.96
10,560.00
8.73
2,520
13.44
55.09
4,429.80
1,49,924.56
70.32
13,886.20
20.34
2,138
-26.91
50.44
1,351.80
1,09,195.79
28.36
29,044.60
2.24
3,870
-55.32
43.59
1,070.80
1,07,747.54
21.10
26,719.70
13.65
5,242
7.82
55.72
2,351.60
1,07,478.28
#1 19.87
27,487.50
19.98
5,345
#1 87.72
62.62
1,272.10
1,06,174.94
25.45
33,593.30
-0.44
3,998
-86.05
45.29
2,414.20
99,659.40
51.25
14,277.60
12.03
1,750
31.75
56.36
1,497.80
86,992.47
23.93
33,384.70
3.21
3,376
1.99
59.92
1,412.90
76,276.34
83.13
6,867.80
#1 22.01
890
21.18
63.84
Growth Rate
Revenue Growth
0.26 %
Net Income Growth
-52.46 %
Cash Flow Change
20.36 %
ROE
-59.13 %
ROCE
-36.17 %
EBITDA Margin (Avg.)
-16.63 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
64
64
75
79
71
72
99
95
69
68
74
72
71
88
76
75
65
78
87
107
95
101
103
106
69
87
97
119
83
94
98
110
73
91
110
111
Expenses
57
55
64
62
62
61
85
84
64
63
65
62
60
81
67
65
59
67
76
90
82
87
88
90
63
77
85
102
74
83
85
94
68
83
96
98
EBITDA
7
9
11
17
9
11
13
11
4
5
9
9
11
8
8
10
7
11
11
16
13
14
16
16
6
11
13
17
9
11
13
16
6
8
15
13
Operating Profit %
11 %
13 %
15 %
13 %
12 %
14 %
13 %
11 %
5 %
7 %
11 %
10 %
15 %
9 %
10 %
12 %
8 %
13 %
12 %
14 %
12 %
12 %
13 %
15 %
7 %
11 %
12 %
13 %
10 %
10 %
12 %
13 %
6 %
6 %
12 %
7 %
Depreciation
2
2
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
4
4
4
4
5
5
5
5
5
5
5
5
Interest
2
3
2
3
3
3
3
3
3
3
3
3
3
3
2
3
3
3
2
1
1
1
2
1
2
1
2
2
3
3
3
3
3
3
3
3
Profit Before Tax
3
4
7
11
4
5
8
5
-2
-2
2
3
4
1
2
3
0
4
6
11
8
8
10
10
0
5
7
11
1
3
6
8
-2
-0
6
5
Tax
1
1
1
3
0
1
2
3
-3
-1
0
0
1
0
1
1
0
1
2
4
2
3
3
3
0
1
2
3
0
1
2
3
-1
0
2
1
Net Profit
2
3
6
8
4
3
6
2
0
-1
2
2
3
1
1
2
0
3
4
7
5
5
7
7
0
4
5
8
1
2
4
5
-2
-0
4
4
EPS in ₹
2.66
1.79
7.81
4.84
2.35
2.08
3.65
1.43
0.05
-0.37
0.94
1.41
2.02
0.73
0.80
0.95
0.12
2.00
2.51
4.33
3.17
3.35
1.35
1.48
0.05
0.85
0.98
1.66
0.18
0.49
0.82
1.01
-0.38
-0.09
0.90
0.76

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
265
256
259
298
329
325
325
342
342
447
472
539
Fixed Assets
87
92
89
94
106
116
107
106
109
161
164
162
Current Assets
168
154
154
173
194
182
192
212
191
228
231
276
Capital Work in Progress
6
3
4
8
13
10
11
12
27
42
71
96
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
172
161
166
196
209
200
208
224
206
244
237
282
Total Equity & Liabilities
265
256
259
298
329
325
325
342
342
447
472
539
Current Liabilities
133
122
113
141
155
143
142
146
111
159
166
190
Non Current Liabilities
38
35
28
20
22
28
22
20
30
49
53
53
Total Equity
94
99
118
137
151
154
161
176
200
239
252
296
Reserve & Surplus
86
91
110
129
135
138
145
160
152
190
202
240
Share Capital
8
8
8
8
16
16
16
16
49
49
49
54

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-7
-0
-0
1
-1
1
-0
2
3
3
-8
23
Investing Activities
-9
-12
-7
-26
-21
-19
-6
-14
-36
-73
-40
-55
Operating Activities
6
22
32
37
35
22
32
49
38
16
41
50
Financing Activities
-4
-10
-25
-10
-15
-2
-26
-33
1
60
-9
28

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
30.34 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.21 %
0.01 %
0.03 %
0.00 %
0.02 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.11 %
0.10 %
0.24 %
0.24 %
0.24 %
0.24 %
0.20 %
0.07 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.73 %
51.92 %
51.96 %
50.67 %
50.77 %
51.15 %
50.96 %
51.57 %
51.57 %
49.90 %
50.74 %
50.92 %
49.01 %
49.21 %
45.48 %
44.39 %
47.78 %
47.50 %
48.20 %
36.63 %
32.77 %
Others
36.01 %
14.81 %
14.77 %
16.06 %
15.97 %
15.59 %
15.78 %
15.17 %
15.16 %
16.84 %
15.99 %
15.82 %
17.72 %
17.42 %
21.15 %
21.90 %
18.71 %
18.96 %
18.30 %
29.89 %
36.81 %
No of Share Holders
4,600
4,887
4,610
3,646
3,561
3,569
3,643
5,595
5,879
8,982
15,305
17,342
17,100
17,483
17,716
17,450
17,448
16,641
17,282
17,251
16,762

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Jun 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Jun 2026 107.61 119.45
BONUS Bonus
1:1
04 Oct 2018 55.33 0.00
29 Jun 2022 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
29 Jun 2022 77.67 63.50
22 Dec 2022 BONUS Bonus
2:1
22 Dec 2022 105.18 110.83
27 Jun 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Jun 2024 102.30 105.00
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 106.99 113.35
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 101.05 106.72
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 88.41 92.99
27 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Jun 2025 88.14 112.62
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 111.70 79.30
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 73.32 77.62
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 72.23 77.82
16 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
16 Feb 2026 76.10 71.79
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2026 109.14 97.41

Announcements

Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 20114 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2026
Letter Sent To MembersJun 05, 2026
Reg. 34 (1) Annual Report.Jun 05, 2026
The Notice Of 42Nd Annual General Meeting For The F.Y 2025-26Jun 05, 2026
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jun 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2026
Earnings Presentation Q4 & FY26May 19, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2026
Results - Financial Results For 31.03.2026May 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 19, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 19.05.2026May 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2026
Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financial Results For The Year Eneded 31St March 2026.May 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 08, 2026
Update - Completion Of EU-GMP Inspection / AuditMay 08, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 18, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Intimation Of Appointment Of Internal Auditor Of The CompanyMar 30, 2026
Closure of Trading WindowMar 27, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 18, 2026
Announcement Under Regulation 30- Constitution Of Advisory BoardMar 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Announcement under Regulation 30 (LODR)-AllotmentMar 13, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 23, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 16, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Disclosure Under Regulation- 30Feb 11, 2026
Disclosure Under Regulation- 30Feb 11, 2026
Disclosure Under Regulation 30- Incorporation Of Wholly Owned SubsidiaryFeb 11, 2026
Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended 31St December 2025Feb 11, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held To Consider And Approve Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2025Feb 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On December 31 2025.Feb 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2026
Notice Of Extra-Ordinary General Meeting Of The CompanyJan 23, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2026

Technical Indicators

RSI(14)
Neutral
70.91
ATR(14)
Volatile
6.59
STOCH(9,6)
Neutral
76.15
STOCH RSI(14)
Neutral
45.64
MACD(12,26)
Bullish
0.10
ADX(14)
Strong Trend
28.86
UO(9)
Bearish
65.60
ROC(12)
Uptrend And Accelerating
10.70
WillR(14)
Overbought
-1.17